GO TO CORPORATE ABOUT US WHAT WE DO INVESTOR & MEDIA CAREERS INNOVATIVE SCIENCE We are pioneering the next generation of cancer immunotherapies and vaccines for infectious diseases OUR FOCUS We focus on research, development and manufacture of novel cancer immunotherapies and vaccines for infectious diseases. THERAPEUTIC AREAS NEWS & EVENTS NEWS EVENTS October 09, 2015 Bavarian Nordic Announces Initiation of Safety and Immunogenicity Study of Ebola Vaccine Regimen in Sierra Leone September 30, 2015 Total number of voting rights and share capital in Bavarian Nordic A/S September 14, 2015 Bavarian Nordic Receives Contract Valued at USD 9 Million from Janssen as part of Advanced Development of Prime-Boost Ebola Vaccine Regimen View more EBOLA Volunteer Idrissa Kamara receives the first dose of the prime-boost Ebola vaccine in new study in Sierra Leone. Read more INVESTOR Stock price 259.50 Last (DKK) 0.50 Change (DKK) Investor CONTACT US +45 33 26 83 83 info@bavarian-nordic.com FOLLOW US ABOUT US Bavarian Nordic is a biopharmaceutical company focused on the development and manufacturing of cancer immunotherapies and vaccines for infectious diseases. OUR LOCATIONS © 2015 Bavarian Nordic | Disclaimer/Privacy | Cookies | Sitemap This website uses cookies to collect statistical information on the use of our website with the goal of improving user experience. To find out more about cookies on this website, see our cookie policy.

GO TO CORPORATE ABOUT US WHAT WE DO INVESTOR & MEDIA CAREERS ARTICLES OF ASSOCIATION Updated on September 8, 2015. The articles can be downloaded in PDF format here. Click here for Danish version. NAME, OBJECTS OF THE COMPANY AND CORPORATE LANGUAGE View more THE COMPANY'S SHARE CAPITAL View more AUTHORISATION TO INCREASE THE CAPITAL STOCK View more SHARES View more GENERAL MEETINGS View more VOTING RIGHTS View more BOARD OF DIRECTORS AND BOARD OF MANAGEMENT View more BINDING SIGNATURES View more AUDITORS View more ACCOUNTS View more APPENDIX 1 View more Corporate Governance Corporate Governance Reports Articles of Association Remuneration Policy Diversity in the Board CONTACT US +45 33 26 83 83 info@bavarian-nordic.com FOLLOW US ABOUT US Bavarian Nordic is a biopharmaceutical company focused on the development and manufacturing of cancer immunotherapies and vaccines for infectious diseases. OUR LOCATIONS © 2015 Bavarian Nordic | Disclaimer/Privacy | Cookies | Sitemap This website uses cookies to collect statistical information on the use of our website with the goal of improving user experience. To find out more about cookies on this website, see our cookie policy.